Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.42398061 |
2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.42398061 |
3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.38663513 |
4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.02424312 |
5 | leukocyte aggregation (GO:0070486) | 4.66847972 |
6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.46229117 |
7 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.28904984 |
8 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.28606102 |
9 | detection of other organism (GO:0098543) | 4.28563316 |
10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.16544950 |
11 | negative regulation of cell killing (GO:0031342) | 4.16544950 |
12 | positive thymic T cell selection (GO:0045059) | 4.15894702 |
13 | detection of bacterium (GO:0016045) | 4.13782994 |
14 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.07435518 |
15 | regulation of gamma-delta T cell activation (GO:0046643) | 3.87931156 |
16 | negative regulation of phagocytosis (GO:0050765) | 3.76251106 |
17 | negative thymic T cell selection (GO:0045060) | 3.76217153 |
18 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.75598821 |
19 | negative T cell selection (GO:0043383) | 3.71513711 |
20 | detection of external biotic stimulus (GO:0098581) | 3.70876569 |
21 | T cell migration (GO:0072678) | 3.65240867 |
22 | positive regulation by symbiont of host defense response (GO:0052509) | 3.64234161 |
23 | modulation by symbiont of host defense response (GO:0052031) | 3.64234161 |
24 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.64234161 |
25 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.64234161 |
26 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.64234161 |
27 | modulation by symbiont of host immune response (GO:0052553) | 3.64234161 |
28 | detection of molecule of bacterial origin (GO:0032490) | 3.61932485 |
29 | regulation of B cell differentiation (GO:0045577) | 3.54886279 |
30 | B cell receptor signaling pathway (GO:0050853) | 3.53261340 |
31 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.51021939 |
32 | thymic T cell selection (GO:0045061) | 3.49805742 |
33 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.45614721 |
34 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.44453611 |
35 | cellular extravasation (GO:0045123) | 3.42607111 |
36 | tolerance induction (GO:0002507) | 3.41290953 |
37 | positive regulation of B cell differentiation (GO:0045579) | 3.40406064 |
38 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.40105146 |
39 | response to host immune response (GO:0052572) | 3.40105146 |
40 | germinal center formation (GO:0002467) | 3.38972269 |
41 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.35637258 |
42 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.35315165 |
43 | response to interleukin-15 (GO:0070672) | 3.31883539 |
44 | leukocyte cell-cell adhesion (GO:0007159) | 3.31292940 |
45 | regulation of mast cell degranulation (GO:0043304) | 3.30877003 |
46 | response to host (GO:0075136) | 3.28665768 |
47 | response to host defenses (GO:0052200) | 3.28665768 |
48 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.28665768 |
49 | granulocyte activation (GO:0036230) | 3.28641034 |
50 | immunoglobulin mediated immune response (GO:0016064) | 3.27762300 |
51 | detection of biotic stimulus (GO:0009595) | 3.23961505 |
52 | positive regulation of lamellipodium assembly (GO:0010592) | 3.23158988 |
53 | myeloid cell activation involved in immune response (GO:0002275) | 3.19322054 |
54 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.19245555 |
55 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.18969209 |
56 | positive T cell selection (GO:0043368) | 3.16845012 |
57 | negative regulation of interleukin-12 production (GO:0032695) | 3.15293479 |
58 | negative regulation of T cell mediated immunity (GO:0002710) | 3.14494291 |
59 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.13620949 |
60 | T cell selection (GO:0045058) | 3.10464793 |
61 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.10103779 |
62 | regulation of T cell tolerance induction (GO:0002664) | 3.08244198 |
63 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.07433497 |
64 | regulation of leukocyte degranulation (GO:0043300) | 3.05688147 |
65 | NIK/NF-kappaB signaling (GO:0038061) | 3.01581709 |
66 | macrophage activation (GO:0042116) | 3.01341167 |
67 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.00015485 |
68 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.99887137 |
69 | cellular response to interleukin-15 (GO:0071350) | 2.98663684 |
70 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.98571636 |
71 | interferon-gamma production (GO:0032609) | 2.96828466 |
72 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.96571819 |
73 | response to muramyl dipeptide (GO:0032495) | 2.96330869 |
74 | microglial cell activation (GO:0001774) | 2.94372166 |
75 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.92074923 |
76 | T cell costimulation (GO:0031295) | 2.91802971 |
77 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.89602468 |
78 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.89198862 |
79 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.88239923 |
80 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.87554149 |
81 | response to laminar fluid shear stress (GO:0034616) | 2.86969594 |
82 | lymphocyte costimulation (GO:0031294) | 2.86731820 |
83 | T cell receptor signaling pathway (GO:0050852) | 2.85278053 |
84 | positive regulation of mast cell activation (GO:0033005) | 2.84066259 |
85 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.83839481 |
86 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.83493078 |
87 | neutrophil activation involved in immune response (GO:0002283) | 2.82556609 |
88 | positive regulation of lamellipodium organization (GO:1902745) | 2.82272304 |
89 | sequestering of actin monomers (GO:0042989) | 2.81811193 |
90 | positive regulation of isotype switching (GO:0045830) | 2.80022320 |
91 | T-helper 1 type immune response (GO:0042088) | 2.79286982 |
92 | negative regulation of type 2 immune response (GO:0002829) | 2.78405777 |
93 | regulation of antigen processing and presentation (GO:0002577) | 2.78378751 |
94 | natural killer cell differentiation (GO:0001779) | 2.77532723 |
95 | actin nucleation (GO:0045010) | 2.75579014 |
96 | myeloid dendritic cell activation (GO:0001773) | 2.74557163 |
97 | respiratory burst (GO:0045730) | 2.74500204 |
98 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.74274392 |
99 | B cell mediated immunity (GO:0019724) | 2.73609800 |
100 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.72751808 |
101 | positive regulation of interferon-alpha production (GO:0032727) | 2.72743122 |
102 | regulation of mast cell activation (GO:0033003) | 2.72465538 |
103 | morphogenesis of an endothelium (GO:0003159) | 2.72317051 |
104 | endothelial tube morphogenesis (GO:0061154) | 2.72317051 |
105 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.72031566 |
106 | positive regulation of histone deacetylation (GO:0031065) | 2.71515632 |
107 | response to peptidoglycan (GO:0032494) | 2.70561612 |
108 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.69796293 |
109 | negative regulation of granulocyte differentiation (GO:0030853) | 2.69143726 |
110 | positive regulation of tolerance induction (GO:0002645) | 2.69067118 |
111 | response to type I interferon (GO:0034340) | 2.69031999 |
112 | regulation of type 2 immune response (GO:0002828) | 2.68273241 |
113 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.67400630 |
114 | negative regulation of interleukin-6 production (GO:0032715) | 2.67012833 |
115 | regulation of interferon-alpha production (GO:0032647) | 2.66139516 |
116 | negative regulation of innate immune response (GO:0045824) | 2.66084085 |
117 | positive regulation of macrophage differentiation (GO:0045651) | 2.65424113 |
118 | myeloid dendritic cell differentiation (GO:0043011) | 2.64852345 |
119 | positive regulation of type 2 immune response (GO:0002830) | 2.64534760 |
120 | regulation of macrophage cytokine production (GO:0010935) | 2.64289737 |
121 | cellular response to type I interferon (GO:0071357) | 2.64142460 |
122 | type I interferon signaling pathway (GO:0060337) | 2.64142460 |
123 | regulation of response to interferon-gamma (GO:0060330) | 2.63807881 |
124 | macrophage activation involved in immune response (GO:0002281) | 2.63448196 |
125 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.63382750 |
126 | response to protozoan (GO:0001562) | 2.63166349 |
127 | mature B cell differentiation (GO:0002335) | 2.62418880 |
128 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.58012169 |
129 | cellular response to zinc ion (GO:0071294) | 2.56580101 |
130 | T cell homeostasis (GO:0043029) | 2.56544918 |
131 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.56302328 |
132 | neutrophil activation (GO:0042119) | 2.55971130 |
133 | lymphocyte homeostasis (GO:0002260) | 2.55663099 |
134 | defense response to protozoan (GO:0042832) | 2.54053480 |
135 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.53747765 |
136 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.53396808 |
137 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.50562440 |
138 | regulation of tolerance induction (GO:0002643) | 2.50422957 |
139 | pinocytosis (GO:0006907) | 2.50036632 |
140 | positive regulation of interleukin-2 production (GO:0032743) | 2.49709292 |
141 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.49034169 |
142 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.49034169 |
143 | positive regulation of antigen processing and presentation (GO:0002579) | 2.48709294 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.27901729 |
2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.90602342 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.72336121 |
4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.68204864 |
5 | MYC_22102868_ChIP-Seq_BL_Human | 3.46041945 |
6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.38708569 |
7 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.32591450 |
8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.12653924 |
9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.12570122 |
10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.93667212 |
11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.81831050 |
12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.66939565 |
13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.64417560 |
14 | MAF_26560356_Chip-Seq_TH1_Human | 2.59803927 |
15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.54382067 |
16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.52424147 |
17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.49568018 |
18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.44377567 |
19 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.43826929 |
20 | MYB_26560356_Chip-Seq_TH2_Human | 2.39205498 |
21 | UTX_26944678_Chip-Seq_JUKART_Human | 2.32985365 |
22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.32685115 |
23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.30938199 |
24 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.26311446 |
25 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.24718497 |
26 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.24311898 |
27 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.20863752 |
28 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.17527700 |
29 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.16614769 |
30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.12294297 |
31 | MYB_26560356_Chip-Seq_TH1_Human | 2.10732945 |
32 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.10420702 |
33 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.07041054 |
34 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.06860777 |
35 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.05194223 |
36 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.04938076 |
37 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.04123321 |
38 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.00926771 |
39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.99294948 |
40 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.88040178 |
41 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.87098823 |
42 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.87046092 |
43 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.85934894 |
44 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.82201263 |
45 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.80346823 |
46 | SPI1_23127762_ChIP-Seq_K562_Human | 1.74005188 |
47 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.70349320 |
48 | MAF_26560356_Chip-Seq_TH2_Human | 1.67294141 |
49 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.66564356 |
50 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.59365295 |
51 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56687637 |
52 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55543804 |
53 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47884700 |
54 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.46935282 |
55 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.43921682 |
56 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37944602 |
57 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.35151204 |
58 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.25980415 |
59 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.24439065 |
60 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23823021 |
61 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23662770 |
62 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21950031 |
63 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.21282099 |
64 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.20827341 |
65 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.20161234 |
66 | GATA1_19941826_ChIP-Seq_K562_Human | 1.19665565 |
67 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.19459428 |
68 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19205327 |
69 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.18989451 |
70 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.18771980 |
71 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.14239560 |
72 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.14007193 |
73 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.13604223 |
74 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11420819 |
75 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.10630883 |
76 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10527059 |
77 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.09625833 |
78 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.09599001 |
79 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08928955 |
80 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.08339638 |
81 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07317381 |
82 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06857520 |
83 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.05619246 |
84 | KDM2B_26808549_Chip-Seq_K562_Human | 1.05466023 |
85 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04218290 |
86 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04161537 |
87 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.02659172 |
88 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02369087 |
89 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.01454884 |
90 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.98259823 |
91 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.97230796 |
92 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.94933121 |
93 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.94722438 |
94 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90647965 |
95 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.90575743 |
96 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89784652 |
97 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.89199148 |
98 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87355714 |
99 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.87350678 |
100 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.85941303 |
101 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.85275520 |
102 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.84586796 |
103 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.83055999 |
104 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82493401 |
105 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.82185140 |
106 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81670952 |
107 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.81290391 |
108 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.80814750 |
109 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79789177 |
110 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79477037 |
111 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.79152422 |
112 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.78601686 |
113 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.78476011 |
114 | GATA3_26560356_Chip-Seq_TH2_Human | 0.78293503 |
115 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.78168755 |
116 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77727315 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 3.42107697 |
2 | MP0003303_peritoneal_inflammation | 3.16013755 |
3 | MP0000685_abnormal_immune_system | 3.12321040 |
4 | MP0003436_decreased_susceptibility_to | 2.99897415 |
5 | MP0005671_abnormal_response_to | 2.80084976 |
6 | MP0001800_abnormal_humoral_immune | 2.75607817 |
7 | MP0001790_abnormal_immune_system | 2.74354092 |
8 | MP0005387_immune_system_phenotype | 2.74354092 |
9 | MP0005000_abnormal_immune_tolerance | 2.58314641 |
10 | MP0009785_altered_susceptibility_to | 2.54577957 |
11 | MP0002452_abnormal_antigen_presenting | 2.53188890 |
12 | MP0003763_abnormal_thymus_physiology | 2.51099172 |
13 | MP0003300_gastrointestinal_ulcer | 2.42835454 |
14 | MP0002420_abnormal_adaptive_immunity | 2.38381314 |
15 | MP0001819_abnormal_immune_cell | 2.36371975 |
16 | MP0002723_abnormal_immune_serum | 2.34865942 |
17 | MP0005025_abnormal_response_to | 2.31230346 |
18 | MP0009278_abnormal_bone_marrow | 2.29865505 |
19 | MP0002419_abnormal_innate_immunity | 2.24073435 |
20 | MP0002398_abnormal_bone_marrow | 2.20910853 |
21 | MP0002396_abnormal_hematopoietic_system | 2.18605038 |
22 | MP0002405_respiratory_system_inflammati | 2.15653585 |
23 | MP0009333_abnormal_splenocyte_physiolog | 2.13668053 |
24 | MP0006082_CNS_inflammation | 2.09770309 |
25 | MP0010352_gastrointestinal_tract_polyps | 2.09658459 |
26 | MP0004808_abnormal_hematopoietic_stem | 2.01588733 |
27 | MP0000716_abnormal_immune_system | 1.97538317 |
28 | MP0005464_abnormal_platelet_physiology | 1.94001669 |
29 | MP0002166_altered_tumor_susceptibility | 1.93964074 |
30 | MP0002148_abnormal_hypersensitivity_rea | 1.93932056 |
31 | MP0005451_abnormal_body_composition | 1.90212896 |
32 | MP0004510_myositis | 1.87478457 |
33 | MP0004947_skin_inflammation | 1.87317511 |
34 | MP0000689_abnormal_spleen_morphology | 1.84131135 |
35 | MP0002722_abnormal_immune_system | 1.81612245 |
36 | MP0010155_abnormal_intestine_physiology | 1.77212819 |
37 | MP0002933_joint_inflammation | 1.72561259 |
38 | MP0003724_increased_susceptibility_to | 1.71881289 |
39 | MP0001853_heart_inflammation | 1.71443276 |
40 | MP0001533_abnormal_skeleton_physiology | 1.69610526 |
41 | MP0002429_abnormal_blood_cell | 1.67976174 |
42 | MP0003566_abnormal_cell_adhesion | 1.66860193 |
43 | MP0000703_abnormal_thymus_morphology | 1.64249267 |
44 | MP0000858_altered_metastatic_potential | 1.63802712 |
45 | MP0003448_altered_tumor_morphology | 1.63378683 |
46 | MP0005397_hematopoietic_system_phenotyp | 1.63238657 |
47 | MP0001545_abnormal_hematopoietic_system | 1.63238657 |
48 | MP0008260_abnormal_autophagy | 1.62089818 |
49 | MP0005076_abnormal_cell_differentiation | 1.61695126 |
50 | MP0008438_abnormal_cutaneous_collagen | 1.61400653 |
51 | MP0003279_aneurysm | 1.58484732 |
52 | MP0002006_tumorigenesis | 1.57260409 |
53 | MP0001845_abnormal_inflammatory_respons | 1.53309511 |
54 | MP0005023_abnormal_wound_healing | 1.52947931 |
55 | MP0001873_stomach_inflammation | 1.47381170 |
56 | MP0003705_abnormal_hypodermis_morpholog | 1.47011520 |
57 | MP0000465_gastrointestinal_hemorrhage | 1.39194729 |
58 | MP0000490_abnormal_crypts_of | 1.34553133 |
59 | MP0005058_abnormal_lysosome_morphology | 1.29141183 |
60 | MP0003866_abnormal_defecation | 1.22806897 |
61 | MP0003091_abnormal_cell_migration | 1.22255805 |
62 | MP0000343_altered_response_to | 1.17080353 |
63 | MP0005164_abnormal_response_to | 1.16449777 |
64 | MP0004883_abnormal_blood_vessel | 1.15243180 |
65 | MP0010307_abnormal_tumor_latency | 1.15019749 |
66 | MP0002132_abnormal_respiratory_system | 1.12680059 |
67 | MP0003828_pulmonary_edema | 1.09764102 |
68 | MP0000604_amyloidosis | 1.09195508 |
69 | MP0001851_eye_inflammation | 1.08003676 |
70 | MP0006054_spinal_hemorrhage | 1.07442465 |
71 | MP0002998_abnormal_bone_remodeling | 1.07110910 |
72 | MP0008469_abnormal_protein_level | 1.05918741 |
73 | MP0003183_abnormal_peptide_metabolism | 1.05141986 |
74 | MP0003172_abnormal_lysosome_physiology | 1.04281343 |
75 | MP0003045_fibrosis | 1.01504236 |
76 | MP0002019_abnormal_tumor_incidence | 0.99705292 |
77 | MP0005390_skeleton_phenotype | 0.97363257 |
78 | MP0001958_emphysema | 0.97235527 |
79 | MP0000733_abnormal_muscle_development | 0.90900021 |
80 | MP0005310_abnormal_salivary_gland | 0.89369545 |
81 | MP0008004_abnormal_stomach_pH | 0.88157628 |
82 | MP0001849_ear_inflammation | 0.87767509 |
83 | MP0002138_abnormal_hepatobiliary_system | 0.87678599 |
84 | MP0004381_abnormal_hair_follicle | 0.87225488 |
85 | MP0003690_abnormal_glial_cell | 0.85671674 |
86 | MP0003453_abnormal_keratinocyte_physiol | 0.83953392 |
87 | MP0000767_abnormal_smooth_muscle | 0.83932483 |
88 | MP0001663_abnormal_digestive_system | 0.83425698 |
89 | MP0003191_abnormal_cellular_cholesterol | 0.81735597 |
90 | MP0008007_abnormal_cellular_replicative | 0.81423474 |
91 | MP0000249_abnormal_blood_vessel | 0.80908993 |
92 | MP0001542_abnormal_bone_strength | 0.79940890 |
93 | MP0005174_abnormal_tail_pigmentation | 0.74988305 |
94 | MP0001915_intracranial_hemorrhage | 0.74966419 |
95 | MP0003795_abnormal_bone_structure | 0.73121605 |
96 | MP0003077_abnormal_cell_cycle | 0.72413232 |
97 | MP0002332_abnormal_exercise_endurance | 0.71954516 |
98 | MP0009764_decreased_sensitivity_to | 0.71747225 |
99 | MP0004858_abnormal_nervous_system | 0.70283824 |
100 | MP0000569_abnormal_digit_pigmentation | 0.70201221 |
101 | MP0005166_decreased_susceptibility_to | 0.68333043 |
102 | MP0009840_abnormal_foam_cell | 0.67217930 |
103 | MP0001243_abnormal_dermal_layer | 0.66577467 |
104 | MP0002277_abnormal_respiratory_mucosa | 0.66403819 |
105 | MP0008874_decreased_physiological_sensi | 0.65309598 |
106 | MP0000477_abnormal_intestine_morphology | 0.62778803 |
107 | MP0009763_increased_sensitivity_to | 0.62504889 |
108 | MP0003656_abnormal_erythrocyte_physiolo | 0.60221898 |
109 | MP0009765_abnormal_xenobiotic_induced | 0.59213439 |
110 | MP0001879_abnormal_lymphatic_vessel | 0.58875981 |
111 | MP0003075_altered_response_to | 0.58626523 |
112 | MP0000350_abnormal_cell_proliferation | 0.58263646 |
113 | MP0005275_abnormal_skin_tensile | 0.56488375 |
114 | MP0002925_abnormal_cardiovascular_devel | 0.55259449 |
115 | MP0008961_abnormal_basal_metabolism | 0.55164464 |
116 | MP0005621_abnormal_cell_physiology | 0.54864630 |
117 | MP0000313_abnormal_cell_death | 0.54864227 |
118 | MP0002877_abnormal_melanocyte_morpholog | 0.54833652 |
119 | MP0003693_abnormal_embryo_hatching | 0.52810625 |
120 | MP0001348_abnormal_lacrimal_gland | 0.52132389 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 4.53859126 |
2 | Recurrent abscess formation (HP:0002722) | 4.40309849 |
3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.05449934 |
4 | Myositis (HP:0100614) | 3.70681705 |
5 | Cellulitis (HP:0100658) | 3.66698151 |
6 | Recurrent fungal infections (HP:0002841) | 3.65391261 |
7 | Recurrent bacterial skin infections (HP:0005406) | 3.63150516 |
8 | Recurrent bronchitis (HP:0002837) | 3.53229514 |
9 | Recurrent viral infections (HP:0004429) | 3.43061111 |
10 | IgM deficiency (HP:0002850) | 3.41522413 |
11 | Chronic otitis media (HP:0000389) | 3.41237056 |
12 | Gastrointestinal infarctions (HP:0005244) | 3.35342435 |
13 | Nasal polyposis (HP:0100582) | 3.26553498 |
14 | Stomatitis (HP:0010280) | 3.25797670 |
15 | Abnormality of the nasal mucosa (HP:0000433) | 3.09182883 |
16 | T lymphocytopenia (HP:0005403) | 3.05339361 |
17 | Spontaneous hematomas (HP:0007420) | 3.01872890 |
18 | Meningitis (HP:0001287) | 2.99292880 |
19 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.98123310 |
20 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.98123310 |
21 | Abnormality of glycolipid metabolism (HP:0010969) | 2.98123310 |
22 | Abnormality of T cell number (HP:0011839) | 2.96506715 |
23 | Mediastinal lymphadenopathy (HP:0100721) | 2.92397135 |
24 | Keratoconjunctivitis sicca (HP:0001097) | 2.92041893 |
25 | Agammaglobulinemia (HP:0004432) | 2.91896387 |
26 | Increased density of long bones (HP:0006392) | 2.86093860 |
27 | Abnormality of T cells (HP:0002843) | 2.84413725 |
28 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.84393194 |
29 | Encephalitis (HP:0002383) | 2.83364525 |
30 | Chronic obstructive pulmonary disease (HP:0006510) | 2.81820581 |
31 | Obstructive lung disease (HP:0006536) | 2.81820581 |
32 | Gastrointestinal inflammation (HP:0004386) | 2.81718269 |
33 | Recurrent cutaneous fungal infections (HP:0011370) | 2.81002332 |
34 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.81002332 |
35 | Inflammation of the large intestine (HP:0002037) | 2.79537183 |
36 | Panhypogammaglobulinemia (HP:0003139) | 2.78913632 |
37 | Cerebral aneurysm (HP:0004944) | 2.76620425 |
38 | Recurrent skin infections (HP:0001581) | 2.73611888 |
39 | Orchitis (HP:0100796) | 2.72578509 |
40 | Autoimmune thrombocytopenia (HP:0001973) | 2.71663133 |
41 | Thrombocytosis (HP:0001894) | 2.68315487 |
42 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.67823148 |
43 | Pustule (HP:0200039) | 2.66843166 |
44 | Abnormality of macrophages (HP:0004311) | 2.64735535 |
45 | Keratoconjunctivitis (HP:0001096) | 2.61004038 |
46 | Vasculitis (HP:0002633) | 2.59738342 |
47 | Verrucae (HP:0200043) | 2.54031860 |
48 | Papilloma (HP:0012740) | 2.54031860 |
49 | Gingivitis (HP:0000230) | 2.51144981 |
50 | Colitis (HP:0002583) | 2.50614200 |
51 | Lymphopenia (HP:0001888) | 2.50547715 |
52 | Abnormality of T cell physiology (HP:0011840) | 2.49596717 |
53 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.46736797 |
54 | Protrusio acetabuli (HP:0003179) | 2.46140774 |
55 | Hematochezia (HP:0002573) | 2.44874223 |
56 | Amyloidosis (HP:0011034) | 2.40992378 |
57 | Emphysema (HP:0002097) | 2.39906062 |
58 | Leukocytosis (HP:0001974) | 2.39806424 |
59 | Interstitial pulmonary disease (HP:0006530) | 2.37365165 |
60 | Dysostosis multiplex (HP:0000943) | 2.37176163 |
61 | Thyroiditis (HP:0100646) | 2.35747930 |
62 | Arterial thrombosis (HP:0004420) | 2.32118426 |
63 | Optic neuritis (HP:0100653) | 2.31246223 |
64 | Retrobulbar optic neuritis (HP:0100654) | 2.31246223 |
65 | Episodic fever (HP:0001954) | 2.28621364 |
66 | Gingival bleeding (HP:0000225) | 2.27876823 |
67 | Severe combined immunodeficiency (HP:0004430) | 2.27686899 |
68 | Combined immunodeficiency (HP:0005387) | 2.27293986 |
69 | Purpura (HP:0000979) | 2.26377342 |
70 | Peritonitis (HP:0002586) | 2.25761537 |
71 | Loss of speech (HP:0002371) | 2.24353083 |
72 | Abnormal platelet volume (HP:0011876) | 2.24215046 |
73 | Abnormality of the fingertips (HP:0001211) | 2.24091561 |
74 | Aortic aneurysm (HP:0004942) | 2.23407769 |
75 | Increased IgE level (HP:0003212) | 2.22767723 |
76 | Abnormality of the peritoneum (HP:0002585) | 2.21205460 |
77 | Chest pain (HP:0100749) | 2.19181832 |
78 | IgG deficiency (HP:0004315) | 2.18297813 |
79 | Osteomyelitis (HP:0002754) | 2.18010703 |
80 | Prolonged bleeding time (HP:0003010) | 2.16467083 |
81 | Aortic dissection (HP:0002647) | 2.15891888 |
82 | Dilatation of the ascending aorta (HP:0005111) | 2.14611752 |
83 | Granulocytopenia (HP:0001913) | 2.13879369 |
84 | Increased cerebral lipofuscin (HP:0011813) | 2.13055573 |
85 | IgA deficiency (HP:0002720) | 2.12386370 |
86 | Pulmonary embolism (HP:0002204) | 2.08654812 |
87 | Pulmonary infiltrates (HP:0002113) | 2.08460928 |
88 | Hemoptysis (HP:0002105) | 2.07288826 |
89 | Hypochromic anemia (HP:0001931) | 2.05951551 |
90 | Eosinophilia (HP:0001880) | 2.05785788 |
91 | Petechiae (HP:0000967) | 2.05347584 |
92 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.04411711 |
93 | Skin ulcer (HP:0200042) | 2.03684766 |
94 | Periodontitis (HP:0000704) | 2.03232573 |
95 | Glomerulopathy (HP:0100820) | 2.02410646 |
96 | Spondylolisthesis (HP:0003302) | 2.01712081 |
97 | Vacuolated lymphocytes (HP:0001922) | 2.00389007 |
98 | Anorexia (HP:0002039) | 1.99342321 |
99 | Increased serum ferritin (HP:0003281) | 1.98369556 |
100 | Gastrointestinal stroma tumor (HP:0100723) | 1.97777996 |
101 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.96844259 |
102 | Osteolytic defects of the hand bones (HP:0009699) | 1.96844259 |
103 | Hypergammaglobulinemia (HP:0010702) | 1.96044370 |
104 | Polycythemia (HP:0001901) | 1.95375963 |
105 | Epistaxis (HP:0000421) | 1.93751006 |
106 | Hepatosplenomegaly (HP:0001433) | 1.92740983 |
107 | Abnormality of eosinophils (HP:0001879) | 1.90184518 |
108 | Premature loss of primary teeth (HP:0006323) | 1.90182392 |
109 | Premature rupture of membranes (HP:0001788) | 1.89375796 |
110 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.89048144 |
111 | Chronic sinusitis (HP:0011109) | 1.88567654 |
112 | Bicuspid aortic valve (HP:0001647) | 1.87784866 |
113 | Abnormality of the pleura (HP:0002103) | 1.87228230 |
114 | Cervical subluxation (HP:0003308) | 1.85160027 |
115 | Abnormal platelet function (HP:0011869) | 1.84398728 |
116 | Impaired platelet aggregation (HP:0003540) | 1.84398728 |
117 | B lymphocytopenia (HP:0010976) | 1.84249823 |
118 | Abnormality of B cell number (HP:0010975) | 1.84249823 |
119 | Hypochromic microcytic anemia (HP:0004840) | 1.83957878 |
120 | Urticaria (HP:0001025) | 1.83368605 |
121 | Increased IgM level (HP:0003496) | 1.83284729 |
122 | Syringomyelia (HP:0003396) | 1.83166446 |
123 | Spinal cord lesions (HP:0100561) | 1.83166446 |
124 | Recurrent lower respiratory tract infections (HP:0002783) | 1.82996666 |
125 | Sepsis (HP:0100806) | 1.82838848 |
126 | Restrictive lung disease (HP:0002091) | 1.82827491 |
127 | Gangrene (HP:0100758) | 1.82774092 |
128 | Abnormality of the pericardium (HP:0001697) | 1.82765286 |
129 | Slow saccadic eye movements (HP:0000514) | 1.82107672 |
130 | Systemic lupus erythematosus (HP:0002725) | 1.81988946 |
131 | Hypertensive crisis (HP:0100735) | 1.81246282 |
132 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.79610781 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 4.62689541 |
2 | PRPF4B | 2.97689893 |
3 | MAP3K10 | 2.85382872 |
4 | TRIB3 | 2.70425012 |
5 | ERN1 | 2.69566952 |
6 | TXK | 2.49766287 |
7 | EEF2K | 2.39585348 |
8 | STK10 | 2.36265396 |
9 | PKN2 | 2.36083182 |
10 | ZAP70 | 2.27442485 |
11 | JAK3 | 2.24180917 |
12 | TYK2 | 2.22306846 |
13 | BLK | 2.15165401 |
14 | TBK1 | 2.12170122 |
15 | TESK2 | 1.85565029 |
16 | BTK | 1.84155502 |
17 | KIT | 1.78861070 |
18 | LRRK2 | 1.77727327 |
19 | ITK | 1.76727267 |
20 | IKBKE | 1.73331474 |
21 | TGFBR2 | 1.72037293 |
22 | GRK6 | 1.68942619 |
23 | TTN | 1.68063958 |
24 | CSF1R | 1.64960508 |
25 | IRAK4 | 1.62386606 |
26 | KDR | 1.57429934 |
27 | RPS6KA4 | 1.54967548 |
28 | HCK | 1.51931016 |
29 | MAP3K14 | 1.49648402 |
30 | JAK1 | 1.47043746 |
31 | FGFR4 | 1.45854284 |
32 | TAOK2 | 1.45546905 |
33 | CSK | 1.45061327 |
34 | EPHB1 | 1.33937419 |
35 | SYK | 1.33505961 |
36 | LCK | 1.32886788 |
37 | IKBKB | 1.29692856 |
38 | MAP2K3 | 1.28929004 |
39 | CDK12 | 1.28707834 |
40 | TEC | 1.28405530 |
41 | SIK2 | 1.25212806 |
42 | SMG1 | 1.20724634 |
43 | MAP3K1 | 1.19713883 |
44 | NME2 | 1.19197441 |
45 | CLK1 | 1.18650604 |
46 | PTK6 | 1.17315241 |
47 | FGFR3 | 1.14898080 |
48 | KSR2 | 1.14496019 |
49 | PIM1 | 1.11455179 |
50 | CDC42BPA | 1.07932227 |
51 | MATK | 1.05267839 |
52 | PIM2 | 1.04800145 |
53 | FES | 1.04035205 |
54 | MOS | 1.03627647 |
55 | MARK3 | 0.99674927 |
56 | TESK1 | 0.99161693 |
57 | PAK4 | 0.97106793 |
58 | TAOK3 | 0.95657172 |
59 | FLT3 | 0.90514840 |
60 | MARK2 | 0.88000627 |
61 | LYN | 0.87287911 |
62 | CHUK | 0.87205873 |
63 | NEK2 | 0.85835748 |
64 | GRK7 | 0.84948115 |
65 | TGFBR1 | 0.84514619 |
66 | BMPR2 | 0.79556994 |
67 | NLK | 0.79200660 |
68 | RIPK1 | 0.77434587 |
69 | RIPK4 | 0.76749122 |
70 | MAP3K11 | 0.76519052 |
71 | BMX | 0.76362765 |
72 | IRAK2 | 0.74253030 |
73 | IRAK3 | 0.72530337 |
74 | PDPK1 | 0.70717342 |
75 | DDR2 | 0.70179446 |
76 | PDK1 | 0.70177045 |
77 | TRPM7 | 0.69663687 |
78 | CDK4 | 0.69311652 |
79 | YES1 | 0.68276251 |
80 | ICK | 0.66146030 |
81 | SIK3 | 0.66057675 |
82 | ALK | 0.65510201 |
83 | IRAK1 | 0.65472646 |
84 | JAK2 | 0.64460702 |
85 | MAPK7 | 0.62836534 |
86 | CDK6 | 0.62426762 |
87 | SIK1 | 0.62302991 |
88 | MAP3K6 | 0.61520898 |
89 | MAP3K8 | 0.61388068 |
90 | PRKCH | 0.60881232 |
91 | MAPK12 | 0.58165879 |
92 | PTK2B | 0.56810827 |
93 | EPHA3 | 0.56153750 |
94 | MAP3K13 | 0.54781477 |
95 | DMPK | 0.54616054 |
96 | MAPKAPK2 | 0.53381187 |
97 | FYN | 0.53174140 |
98 | TNK2 | 0.53140209 |
99 | MAP3K3 | 0.52679746 |
100 | TAOK1 | 0.52158614 |
101 | RPS6KB2 | 0.51125908 |
102 | RPS6KA6 | 0.50185369 |
103 | STK4 | 0.49789979 |
104 | MAP3K7 | 0.49488571 |
105 | SCYL2 | 0.48516825 |
106 | PRKD2 | 0.46858185 |
107 | ILK | 0.46085499 |
108 | PAK2 | 0.45891228 |
109 | STK38 | 0.45501942 |
110 | CAMK1D | 0.45124821 |
111 | PDGFRB | 0.44877622 |
112 | RPS6KA2 | 0.44430018 |
113 | ARAF | 0.43325290 |
114 | PIK3CG | 0.43252109 |
115 | MAP3K5 | 0.42757504 |
116 | PDGFRA | 0.42274827 |
117 | FGR | 0.41878361 |
118 | ABL1 | 0.41725956 |
119 | NEK9 | 0.41671196 |
120 | PTK2 | 0.40909757 |
121 | RPS6KC1 | 0.40585859 |
122 | RPS6KL1 | 0.40585859 |
123 | DYRK1B | 0.39142271 |
124 | PRKG2 | 0.38209260 |
125 | PRKCQ | 0.37515242 |
126 | EGFR | 0.37126844 |
127 | INSR | 0.36527171 |
128 | MAPK4 | 0.36307292 |
129 | MAPKAPK3 | 0.34520283 |
130 | HIPK2 | 0.34253418 |
131 | MTOR | 0.33188489 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.17444567 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.60200153 |
3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.35973451 |
4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.21364395 |
5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.20548799 |
6 | Measles_Homo sapiens_hsa05162 | 2.05593569 |
7 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.98776927 |
8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.97829115 |
9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.97074244 |
10 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.91099677 |
11 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.90100939 |
12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.89419164 |
13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.80127957 |
14 | Viral myocarditis_Homo sapiens_hsa05416 | 1.75310595 |
15 | Shigellosis_Homo sapiens_hsa05131 | 1.73038376 |
16 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.67436412 |
17 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.65008910 |
18 | Malaria_Homo sapiens_hsa05144 | 1.61445738 |
19 | Allograft rejection_Homo sapiens_hsa05330 | 1.59735954 |
20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.59199273 |
21 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.56434317 |
22 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.56309192 |
23 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.53478962 |
24 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.53154134 |
25 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.52109085 |
26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.50413671 |
27 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.44098101 |
28 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.42907526 |
29 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.42734067 |
30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.40941610 |
31 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.40428991 |
32 | Apoptosis_Homo sapiens_hsa04210 | 1.39501137 |
33 | Legionellosis_Homo sapiens_hsa05134 | 1.38475940 |
34 | Pertussis_Homo sapiens_hsa05133 | 1.38145358 |
35 | Tuberculosis_Homo sapiens_hsa05152 | 1.34751432 |
36 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.33700151 |
37 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.32949092 |
38 | Hepatitis B_Homo sapiens_hsa05161 | 1.31955232 |
39 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.31121424 |
40 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.30963978 |
41 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.28789407 |
42 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.27171571 |
43 | Asthma_Homo sapiens_hsa05310 | 1.24743139 |
44 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.24108922 |
45 | Platelet activation_Homo sapiens_hsa04611 | 1.21649606 |
46 | Influenza A_Homo sapiens_hsa05164 | 1.21222500 |
47 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.20864285 |
48 | Salmonella infection_Homo sapiens_hsa05132 | 1.19146074 |
49 | Other glycan degradation_Homo sapiens_hsa00511 | 1.10960657 |
50 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.10459804 |
51 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.08889008 |
52 | HTLV-I infection_Homo sapiens_hsa05166 | 1.08683392 |
53 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.08265317 |
54 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.01470977 |
55 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.98645724 |
56 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.98593844 |
57 | Colorectal cancer_Homo sapiens_hsa05210 | 0.98436415 |
58 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.96454749 |
59 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.94770807 |
60 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.94574813 |
61 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.92397208 |
62 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.91404582 |
63 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.88694454 |
64 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.88330768 |
65 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.88246471 |
66 | Focal adhesion_Homo sapiens_hsa04510 | 0.88149860 |
67 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.87632437 |
68 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.86355404 |
69 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.84332996 |
70 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.83933432 |
71 | Lysosome_Homo sapiens_hsa04142 | 0.81914540 |
72 | Amoebiasis_Homo sapiens_hsa05146 | 0.78801058 |
73 | Adherens junction_Homo sapiens_hsa04520 | 0.75420075 |
74 | Hepatitis C_Homo sapiens_hsa05160 | 0.74775218 |
75 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.72410812 |
76 | Ribosome_Homo sapiens_hsa03010 | 0.71562037 |
77 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.71072225 |
78 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.69232814 |
79 | Base excision repair_Homo sapiens_hsa03410 | 0.68341764 |
80 | DNA replication_Homo sapiens_hsa03030 | 0.68083297 |
81 | Endocytosis_Homo sapiens_hsa04144 | 0.66778747 |
82 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.65761312 |
83 | Prion diseases_Homo sapiens_hsa05020 | 0.62374629 |
84 | Phagosome_Homo sapiens_hsa04145 | 0.58412927 |
85 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.57529528 |
86 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.57088662 |
87 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.56425299 |
88 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.56153470 |
89 | Pathways in cancer_Homo sapiens_hsa05200 | 0.55563119 |
90 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.53688270 |
91 | Spliceosome_Homo sapiens_hsa03040 | 0.53071415 |
92 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.52484461 |
93 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.51908731 |
94 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.51573515 |
95 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.50780927 |
96 | Bladder cancer_Homo sapiens_hsa05219 | 0.49142005 |
97 | Insulin resistance_Homo sapiens_hsa04931 | 0.49071564 |
98 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.48765592 |
99 | Prostate cancer_Homo sapiens_hsa05215 | 0.48302305 |
100 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.48194219 |
101 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47548337 |
102 | Cell cycle_Homo sapiens_hsa04110 | 0.46375510 |
103 | Endometrial cancer_Homo sapiens_hsa05213 | 0.45823836 |
104 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.43824660 |
105 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.43183638 |
106 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41834121 |
107 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.40768464 |
108 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.40424042 |
109 | Glioma_Homo sapiens_hsa05214 | 0.39976811 |
110 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.39846842 |
111 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.38887008 |
112 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.36949030 |
113 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.36736894 |
114 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.32998981 |
115 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.30936856 |